Aussies Wright, Nichols and Cibilic into Bells semis

Widespread anxiety among Arab-Australian women, stemming from the ongoing conflict in Gaza, has been highlighted in a University of NSW study published in The Lancet, revealing increased panic disorder symptoms and a decline in quality of life. The research, involving 410 women with connections to the region, underscores the urgent need for targeted mental health interventions as they grapple with the emotional toll of family safety concerns amidst the violence. Want More Context? 🔎

Lucinda Price, a comedian and author, battled eating disorders for four years before joining an online trial that offered self-paced treatment, leading to her recovery. The InsideOut Institute recently launched a free eClinic providing evidence-based programs for Australians with eating disorders, aiming to improve access to treatment, especially in underserved communities. Want More Context? 🔎

A tornado struck Perth's City Beach, causing extensive damage to multi-million dollar homes, uprooting trees, and leaving streets in disarray. Fortunately, no injuries were reported, but affected families are now seeking temporary accommodation as authorities assess the situation and restore order in the neighborhood. Want More Context? 🔎

Ukrainian activists are protesting a new law that critics claim weakens anti-corruption agencies, jeopardizing Ukraine’s EU aspirations and international support. President Zelenskiy, facing backlash, argues the law is necessary to enhance corruption investigations, while emphasizing the need for a detailed action plan to restore public trust and address institutional issues. Want More Context? 🔎

The World Health Organisation has warned of a resurgence of the chikungunya virus, with 5.6 billion people at risk as outbreaks spread from the Indian Ocean to Europe. Following significant infections in Reunion and imported cases in France, the virus highlights the importance of prevention measures against the Aedes mosquitoes that transmit it. Want More Context? 🔎

Androfeme, a testosterone cream developed in WA, offers a groundbreaking treatment for hypo-active sexual desire dysfunction, a common menopause side effect, but is not covered by the Pharmaceutical Benefits Scheme, costing $100 for a 100-day supply compared to $31.60 for men’s equivalents. Doctors advocate for its inclusion in the PBS to improve accessibility, as ongoing trials explore its effectiveness on additional menopause symptoms. Want More Context? 🔎